INTRODUCTION

Elosulfase alfa (brand name Vimizim) is a recombinant N-acetylgalactosamine-6-sulfatase enzyme that is used for the treatment of Morquio syndrome.

This plasmid is designed for expressing Elosulfase alfa in mammalian Chinese hamster ovary (CHO) cell line.

PRODUCT INFORMATION

Item No.: PPBD-68
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Elosulfase alfa
Brand Name(s): Vimizim
Classification: Recombinant Enzymes
Action Type: Enzyme replacement therapy
Amino Acid Sequence: Identical to DB09051

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

Sanford M, Lo JH. Elosulfase alfa: first global approval. Drugs. 2014 Apr;74(6):713-8. doi: 10.1007/s40265-014-0210-z. PMID: 24700469.

Contact Us